Depakote Sprinklesdivalproex

41,624 adverse event reports submitted to the FDA (1998–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Depakote Sprinkles in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Depakote Sprinkles adverse event reports by reporter sex
SexReports
Female19,518
Male18,001
Unknown297

By Age Group

View age group data as a table
Depakote Sprinkles adverse event reports by reporter age group
Age groupReports
0-172,638
18-344,733
35-495,981
50-646,755
65-742,423
75+1,385

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Depakote Sprinkles. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Depakote Sprinkles adverse event reports by reported outcome
OutcomeReports
Other Serious17,981
Hospitalization13,970
Non-Serious13,266
Death2,326
Life-Threatening1,611
Disability1,274

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Depakote Sprinkles. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Depakote Sprinkles adverse event reports by year
YearReports
19981
20011
20021
20032
20041,147
20051,256
20061,189
20071,180
20081,195
20092,479
20102,155
20112,052
20122,044
20131,760
20141,853
20152,475
20162,644
20172,205
20182,092
20192,129
20201,907
20211,990
20222,042
20231,769
20241,777
20251,859
2026 (partial)420

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Depakote Sprinkles

In FDA adverse event reports that mention Depakote Sprinkles, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026